Clinical Trial Update: Zalutumumab Pharmacokinetics (PK) in Squamous Cell Carcinoma of the Head and Neck (SCCHN) [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update reports pharmacokinetic data for zalutumumab in head and neck cancer patients across Phase 1 and Phase 2; study is completed with results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Zalutumumab (zalutumumab)

Snippet

Sponsor: Genmab | Conditions: Head and Neck Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-01-03